{
    "2018-08-31": [
        [
            {
                "time": "2018-08-31",
                "original_text": "Biotech, Fund Flows, Including ETF Activity, Remain a Driver to Watch",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Fund Flows",
                        "ETF Activity"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "After Hours Most Active for Aug 31, 2018: MU, AAPL, ILG, CSCO, GE, VAC, QQQ, UIS, MSFT, F, PFE, FDC",
                "features": {
                    "keywords": [
                        "MU",
                        "AAPL",
                        "PFE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "How Eli Lilly’s Business Segments Performed in Q2 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "One sector is beating tech this quarter, but one technician sees a ceiling",
                "features": {
                    "keywords": [
                        "sector",
                        "beating tech",
                        "ceiling"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "other sectors"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Pfizer Discontinues Studies on DMD Candidate Domagrozumab",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "DMD",
                        "Domagrozumab"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Analyzing Eli Lilly’s Q2 2018 Revenue Trend",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Revenue Trend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus",
                "features": {
                    "keywords": [
                        "NVS",
                        "ABBV",
                        "MRK",
                        "Cancer Drugs",
                        "HIV Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "Eli Lilly’s Valuation on August 30",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Valuation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-31",
                "original_text": "Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus",
                "features": {
                    "keywords": [
                        "NVS",
                        "ABBV",
                        "MRK",
                        "Cancer Drugs",
                        "HIV Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-04",
                "original_text": "Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 04, 2018",
                "features": {
                    "keywords": [
                        "Phibro",
                        "Ex-Dividend",
                        "PAHC"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "animal health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "4 Large Cap Pharma Stocks in Focus on Robust Cancer Pipeline",
                "features": {
                    "keywords": [
                        "Large Cap",
                        "Pharma",
                        "Cancer Pipeline"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "See what the IHS Markit Score report has to say about Pfizer Inc.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Biotech Stocks Facing FDA Decision In September",
                "features": {
                    "keywords": [
                        "Biotech",
                        "FDA Decision"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}